TIM-3, a common co-inhibitory immune checkpoint in GBM, regulates GBM cell malignancy and induces macrophage migration and polarization toward an anti-inflammatory or pro-tumor phenotype through the IL-6 pathway [33]. Here, HAVCR2 is linked to neoplasm.